Prostaglandin E1 (Liprostin) Treatment With Lower Limb Angioplasty for Peripheral Arterial Occlusive Disease
Status:
Unknown status
Trial end date:
2003-08-01
Target enrollment:
Participant gender:
Summary
This is the first clinical research trial in which intravenous Prostaglandin E1 (PGE1 is a
vasoactive hormone) will be used as supportive treatment along with the angioplasty procedure
to treat or open up a blocked artery within one lower limb or the most affected of two limbs
in subjects with Peripheral Arterial Occlusive Disease.